The Royal Osteoporosis Society (ROS) announced Professor Stuart Ralston as one of the successful applicants of its largest ever research grants round, after reviewing a record number of applications. [scald=147194:sdl_editor_representation {"alt":"Stuart Ralston's team","caption":""}] The aim of the Royal Osteoporosis Society's (ROS) grant programme was to offer researchers the opportunity to apply for funding that would allow them them to undertake pioneering research which would improve the understanding of osteoporosis. The current rate of bone breakage due to osteoporosis is half of women and one fifth of men. Professor Ralston's research proposal aligned with ROS's Research Roadmap which is to create an infrastructure to improve understanding and outcomes of Pregnancy Associated Osteoporosis. I am delighted that we have been awarded this project grant by the Royal Osteoporosis Society to increase understanding of Pregnancy Associated Osteoporosis (PAO). Although this is a rare condition, it is truly devastating for women who are affected. The Royal Osteoporosis Society funding will allow us to establish a UK-wide network of women who have been affected by the condition with the aim of getting an accurate picture of the risk factors for the disease at the time of first diagnosis, was well as tracking its impact on bone health and general health throughout life. By creating this infrastructure we hope to develop tools to assess the risk of developing PAO as well as identifying the best forms of treatment. Professor Stuart Ralston Centre for Genomic & Experimental Medicine Related Links Centre for Genomic & Experimental Medicine Stuart Ralston Research Group Royal Osteoporosis Society (ROS) This article was published on 2022-11-03
